This is a proposal to continue studies on the structure, function, and regulation of the CCK-A receptor. The general hypothesis is that the confirmation, post-translational modifications, and cellular compartmentation of this molecule are in dynamic states in the living cell, and that these processes are ligand and cell-dependent. The investigator proposes that receptor activation is conformationally determined, and proposes to use affinity labeling and receptor mutagenesis to explore athe receptor domains occupied by agonists and antagonists. A second proposal is that post-translational modifications of the receptor provide a secondary level of change, which occurs over time in a ligand-dependent manner, which contributes to direct cellular handling of the receptor. This work will focus on receptor phosphorylation and fatty acid acylation in pancreatic acinar cells and cells transfected with the CCK-A receptor. Finally, it is proposed that the cell possesses multiple distinct mechanisms for desensitization and resensitization to hormonal stimulation. Cellular compartments of desensitization such as clatharin-coated endocytic compartments, caveceolae, and a newly described compartment of insulation will all be examined and related to state of receptor phosphorylation. Together, these studies will provide insight into the physiology of G- protein coupled receptors with the CCK receptor as a model, and as an extension of previous work exploring desensitization uncoupling, sequestration and downregulation of the CCK receptor that were initiated in the previous grant cycle.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK032878-15
Application #
2458735
Study Section
Special Emphasis Panel (ZRG2-PSF (01))
Project Start
1983-08-01
Project End
2001-07-31
Budget Start
1997-08-01
Budget End
1998-07-31
Support Year
15
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Mayo Clinic, Rochester
Department
Type
DUNS #
City
Rochester
State
MN
Country
United States
Zip Code
55905
Desai, Aditya J; Dong, Maoqing; Miller, Laurence J (2016) Beneficial effects of ?-sitosterol on type 1 cholecystokinin receptor dysfunction induced by elevated membrane cholesterol. Clin Nutr 35:1374-1379
Desai, A J; Dong, M; Harikumar, K G et al. (2016) Cholecystokinin-induced satiety, a key gut servomechanism that is affected by the membrane microenvironment of this receptor. Int J Obes Suppl 6:S22-S27
Miller, Laurence J; Desai, Aditya J (2016) Metabolic Actions of the Type 1 Cholecystokinin Receptor: Its Potential as a Therapeutic Target. Trends Endocrinol Metab 27:609-619
Desai, Aditya J; Henke, Brad R; Miller, Laurence J (2015) Elimination of a cholecystokinin receptor agonist 'trigger' in an effort to develop positive allosteric modulators without intrinsic agonist activity. Bioorg Med Chem Lett 25:1849-55
Harikumar, Kaleeckal G; Miller, Laurence J (2015) Use of Fluorescence Indicators in Receptor Ligands. Methods Mol Biol 1335:115-30
Desai, Aditya J; Lam, Polo C H; Orry, Andrew et al. (2015) Molecular Mechanism of Action of Triazolobenzodiazepinone Agonists of the Type 1 Cholecystokinin Receptor. Possible Cooperativity across the Receptor Homodimeric Complex. J Med Chem 58:9562-77
Desai, Aditya J; Dong, Maoqing; Harikumar, Kaleeckal G et al. (2015) Impact of ursodeoxycholic acid on a CCK1R cholesterol-binding site may contribute to its positive effects in digestive function. Am J Physiol Gastrointest Liver Physiol 309:G377-86
Dong, Maoqing; Vattelana, Ashton M; Lam, Polo C-H et al. (2015) Development of a highly selective allosteric antagonist radioligand for the type 1 cholecystokinin receptor and elucidation of its molecular basis of binding. Mol Pharmacol 87:130-40
Desai, Aditya J; Harikumar, Kaleeckal G; Miller, Laurence J (2014) A type 1 cholecystokinin receptor mutant that mimics the dysfunction observed for wild type receptor in a high cholesterol environment. J Biol Chem 289:18314-26
Dong, Maoqing; Miller, Laurence J (2013) Direct demonstration of unique mode of natural peptide binding to the type 2 cholecystokinin receptor using photoaffinity labeling. Peptides 46:143-9

Showing the most recent 10 out of 130 publications